David A. Ramsay
2014
In 2014, David A. Ramsay earned a total compensation of $1.2M as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $129,886 |
|---|---|
| Option Awards | $367,164 |
| Salary | $364,875 |
| Stock Awards | $371,385 |
| Other | $8,669 |
| Total | $1,241,979 |
Ramsay received $371.4K in stock awards, accounting for 30% of the total pay in 2014.
Ramsay also received $129.9K in non-equity incentive plan, $367.2K in option awards, $364.9K in salary and $8.7K in other compensation.
Rankings
In 2014, David A. Ramsay's compensation ranked 6,616th out of 13,032 executives tracked by ExecPay. In other words, Ramsay earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,616 out of 13,032 | 49th |
Division Manufacturing | 2,419 out of 4,966 | 51st |
Major group Chemicals And Allied Products | 816 out of 1,686 | 52nd |
Industry group Drugs | 639 out of 1,365 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 122 out of 236 | 48th |
Source: SEC filing on March 23, 2016.
Ramsay's colleagues
We found four more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2014.